Loading...

APC anti-mouse CD4 Antibody APC anti-mouse CD4 Antibody

Pricing & Availability
Clone
GK1.5 (See other available formats)
Regulatory Status
RUO
Other Names
L3T4, T4
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
GK1.5_APC_102110
C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) APC (filled histogram) or rat IgG2b, κ APC isotype control (open histogram).
  • GK1.5_APC_102110
    C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) APC (filled histogram) or rat IgG2b, κ APC isotype control (open histogram).
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
100411 25 µg DKK232
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100412 100 µg DKK785
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD4 is a 55 kD protein also known as L3T4 or T4. It is a member of the Ig superfamily, primarily expressed on most thymocytes, a subset of T cells, and weakly on macrophages and dendritic cells. It acts as a coreceptor with the TCR during T cell activation and thymic differentiation by binding MHC class II and associating with the protein tyrosin kinase, lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse CTL clone V4
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD4 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: blocking of CD4+ T cell activation1,4,11, thymocyte costimulation3, in vitro and in vivo depletion2,5-8, blocking of egg-sperm cell adhesion1,4, immunohistochemical staining of acetone-fixed frozen sections9,10, immunoprecipitation1,2, and spatial biology (IBEX)12,13. The GK1.5 antibody is able to block CD4 mediated cell adhesion and T cell activation. Binding of GK1.5 antibody to CD4 T cells can be blocked by RM4-5 antibody, but not RM4-4 antibody. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100442) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin < 0.01 EU/µg).

Application References
  1. Dialynas DP, et al. 1983. J. Immunol. 131:2445. (Block, IP)
  2. Dialynas DP, et al. 1983. Immunol. Rev. 74:29. (IP, Deplete)
  3. Wu L, et al. 1991. J. Exp. Med. 174:1617. (Costim)
  4. Godfrey DI, et al. 1994. J. Immunol. 152:4783. (Block)
  5. Gavett SH, et al. 1994. Am. J. Respir. Cell. Mol. Biol. 10:587. (Deplete)
  6. Schuyler M, et al. 1994. Am. J. Respir. Crit. Care Med. 149:1286. (Deplete)
  7. Ghobrial RR, et al. 1989. Clin. Immunol. Immunopathol. 52:486. (Deplete)
  8. Israelski DM, et al. 1989. J. Immunol. 142:954. (Deplete)
  9. Zheng B, et al. 1996. J. Exp. Med. 184:1083. (IHC)
  10. Frei K, et al. 1997. J. Exp. Med. 185:2177. (IHC)
  11. Felix NJ, et al. 2007. Nat. Immunol. 8:388. (Block)
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  2. Glasner A,et al. 2017. Sci Rep.. 10.1038/s41598-017-12998-w. PubMed
  3. Contijoch EJ et al. 2019. eLife. 8 pii: e40553. PubMed
  4. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  5. Taranto D, et al. 2021. Curr Protoc. 1:e147. PubMed
  6. Wu Y, et al. 2021. Immunity. 54:2595. PubMed
  7. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  8. Wang L, et al. 2022. ACS Pharmacol Transl Sci. 5:110. PubMed
  9. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  10. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  11. Campisi L, et al. 2022. Nature. 606:945. PubMed
  12. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  13. Simpson AP, et al. 2022. Cell Rep. 40:111099. PubMed
  14. Shi Z, et al. 2022. Br J Pharmacol. 179:5209. PubMed
  15. Kang IH, et al. 2022. iScience. 25:104818. PubMed
  16. TaSli PN, et al. 2022. J Food Biochem. 46:e14393. PubMed
  17. Sun Y, et al. 2023. Bioact Mater. 22:47. PubMed
  18. Gong F, et al. 2023. Adv Healthc Mater. 12:e2201771. PubMed
  19. VanDyke D, et al. 2022. Cell Rep. 41:111478. PubMed
  20. Chen X, et al. 2022. J Extracell Vesicles. 11:e12279. PubMed
  21. You Q, et al. 2023. Adv Mater. 35:e2204910. PubMed
  22. Wang R, et al. 2023. Nat Biomed Eng. 7:38. PubMed
  23. Edwards CL, et al. 2023. J Clin Invest. 133: . PubMed
  24. Cousin N, et al. 2022. Cells. 12: . PubMed
  25. Roh YJ, et al. 2023. Lab Anim Res. 39:2. PubMed
  26. Lu T, et al. 2023. Cancer Immunol Immunother. :. PubMed
  27. Lee JY, et al. 2023. Cancer Immunol Immunother. :. PubMed
  28. Patton T, et al. 2023. Cell Death Dis. 14:111. PubMed
  29. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  30. Han S, et al. 2022. Cancer Immunol Res. 10:437. PubMed
  31. Fang A, et al. 2022. J Virol. 96:e0105022. PubMed
  32. Dhalech AH, et al. 2022. J Virol. 96:e0123222. PubMed
  33. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  34. McGee MC, et al. 2022. Bio Protoc. 12:. PubMed
  35. Wu R, et al. 2022. Nat Immunol. 23:1536. PubMed
  36. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  37. Wang Y, et al. 2023. J Neuroinflammation. 20:41. PubMed
  38. Guo D, et al. 2023. Cell Biosci. 13:51. PubMed
  39. Tang C, et al. 2023. Nat Commun. 14:1493. PubMed
  40. Tao Q, et al. 2023. Microbiol Spectr. :e0522922. PubMed
  41. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  42. Chen F, et al. 2023. Acta Biomater. 164:387. PubMed
  43. Pandit M, et al. 2023. Nat Commun. 14:2593. PubMed
  44. Li M, et al. 2023. BMC Cancer. 23:497. PubMed
  45. Song S, et al. 2023. Bioact Mater. 28:358. PubMed
  46. Ye S, et al. 2023. Front Oncol. 13:1202750. PubMed
  47. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  48. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  49. Chen N, et al. 2021. Front Immunol. 12:756423. PubMed
  50. Berube A, et al. 2022. Viruses. 14:. PubMed
  51. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  52. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  53. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  54. Gerwing M, et al. 2020. Mol Imaging Biol. 1.959027778. PubMed
  55. Hong M, et al. 2021. Int J Mol Sci. 22:. PubMed
  56. Zhu W, et al. 2021. Onco Targets Ther. 14:2149. PubMed
  57. Geng Z, et al. 2021. Nat Commun. 12:6584. PubMed
  58. Zhu P, et al. 2012. J Cereb Blood Flow Metab. 0.482638889. PubMed
  59. Zhang S, et al. 2022. Acta Pharm Sin B. 12:3124. PubMed
  60. Schmidt V, et al. 2021. J Cell Biol. 220:. PubMed
  61. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  62. Zhang C, et al. 2022. J Extracell Vesicles. 11:e12209. PubMed
  63. Oh DS, et al. 2021. Autophagy. 17:2111. PubMed
  64. Gu H, et al. 2021. Immun Inflamm Dis. 9:1686. PubMed
  65. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  66. Tian X, et al. 2022. Front Immunol. 13:875236. PubMed
  67. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  68. Cai B, et al. 2021. Mol Cancer. 20:165. PubMed
  69. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  70. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  71. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  72. Oghumu S, et al. 2014. Immunology. 143: 109-119. PubMed
  73. Inoue M, et al. 2014. Proc Natl Acad Sci U S A. 111:5295. PubMed
  74. Lo W, Allen D 2012. Nat Immunol. 13:880. PubMed
  75. Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed
  76. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
  77. Britton GJ et al. 2019. Immunity. 50(1):212-224 . PubMed
  78. Yang X, et al. 2019. Oncotarget. 10:4180. PubMed
  79. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  80. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  81. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  82. Alissafi T, et al. 2020. Cell Metabolism. 32(4):591-604.e7. PubMed
  83. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  84. Li K, et al. 2022. J Immunother Cancer. 10:. PubMed
  85. Jia L, et al. 2022. Front Immunol. 13:897879. PubMed
  86. Hongu T, et al. 2022. Nat Cancer. 3:486. PubMed
  87. Canto F, et al. 2016. Sci Rep. 6:28573. PubMed
  88. Ben-Shaanan T, et al. 2016. Nat Med. 10.1038/nm.4133. PubMed
  89. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  90. Pein M, et al. 2020. Nat Commun. 11:1494. PubMed
  91. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  92. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  93. Wei SC, et al. 2020. Cancer Discov. . PubMed
  94. Khatun A, et al. 2021. J Exp Med. 218:. PubMed
  95. Si L, et al. 2022. Nat Biotechnol. 40:1370. PubMed
  96. Shin JE, et al. 2021. Heliyon. 7:e08433. PubMed
  97. Wu C, et al. 2014. J Mol Cell Cardiol. 76:33. PubMed
  98. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  99. Uceda-Castro R, et al. 2022. Cell Rep Med. 3:100821. PubMed
  100. Chen D, et al. 2020. Cancer Immunol Res. 8:883. PubMed
  101. Huang Y, et al. 2020. FASEB J. 34:1768. PubMed
  102. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  103. Freitas JT, et al. 2021. Pigment Cell Melanoma Res. 34:1084. PubMed
  104. Hu G, et al. 2022. Cell Death Dis. 13:640. PubMed
  105. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  106. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  107. Leisegang M, et al. 2016. Clin Cancer Res. 22: 2734 - 2743. PubMed
  108. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  109. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  110. Chisolm DA et al. 2019. Immunity. 51(1):155-168 . PubMed
  111. Li J, et al. 2020. Elife. 9:00. PubMed
  112. Abdul Pari AA, et al. 2020. Cancer Res. 80:2586. PubMed
  113. Wang Y, et al. 2021. Front Immunol. 12:654463. PubMed
  114. Ng SS, et al. 2020. Nat Immunol. 21:1205. PubMed
  115. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  116. Jing Y, et al. 2020. Sci Adv. 6:eaax9455. PubMed
  117. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  118. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  119. Ren G et al. 2017. Molecular cell. 67(6):1049-1058 . PubMed
  120. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  121. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  122. Tang X, et al. 2022. Cell Rep. 41:111673. PubMed
  123. Yang J, et al. 2020. Nature. 586:572. PubMed
  124. Takano T, et al. 2020. Front Immunol. 11:1555. PubMed
  125. Yang W, et al. 2020. Methods Mol Biol. 2111:91. PubMed
  126. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  127. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  128. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  129. Nakajima-Adachi H, et al. 2017. PLoS One. 12(2):e0172795. PubMed
  130. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  131. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  132. Alhosaini K, et al. 2021. Brain Sci. :11. PubMed
  133. Tan YY, et al. 2021. Exp Ther Med. 22:1368. PubMed
  134. Zhou Z, et al. 2022. Infect Immun. 90:e0045321. PubMed
  135. Toyama S, et al. 2021. Int J Mol Sci. 22:. PubMed
  136. Nikolos F, et al. 2022. Nat Commun. 13:1487. PubMed
  137. Clemens E, et al. 2015. J Immunol. 194:898. PubMed
  138. Coronel MM, et al. 2020. Sci Adv. 6:eaba5573. PubMed
  139. Bosnjak B, et al. 2019. Front Immunol. 10:840. PubMed
  140. Zou D, et al. 2020. EBioMedicine. 52:102652. PubMed
  141. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  142. Lu J, et al. 2021. Cell Death Discov. 7:165. PubMed
  143. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  144. Wang R, et al. 2022. Front Immunol. 13:947756. PubMed
  145. Li Z, et al. 2021. MBio. 12:e0254221. PubMed
  146. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  147. Anderson AE, et al. 2022. NPJ Regen Med. 7:6. PubMed
  148. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  149. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  150. Chulpanova DS, et al. 2021. Biology (Basel). 10:. PubMed
  151. Watson MJ, et al. 2021. Nature. 591:645. PubMed
  152. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  153. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  154. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  155. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  156. Shen DD, et al. 2022. Mol Cancer. 21:75. PubMed
  157. He C, et al. 2022. Nat Commun. 13:5459. PubMed
  158. Kwok T, et al. 2022. Front Aging. 3:838943. PubMed
  159. Miyauchi E, et al. 2020. Nature. 585:102. PubMed
  160. X X, et al. 2016. J Immunol . 197: 1683-1691. PubMed
  161. Yu X, et al. 2013. Cancer Res. 73:2093. PubMed
  162. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  163. Garcia-Dominguez D, et al. 2022. Front Immunol. 13:948335. PubMed
  164. Gomzikova MO, et al. 2020. Pharmaceutics. 12:00. PubMed
  165. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  166. Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
  167. Wang L, et al. 2021. Sci Adv. 7:eabj4796. PubMed
  168. Tsai HI, et al. 2021. EMBO Mol Med. 13:e12834. PubMed
  169. Zhu S, et al. 2022. EBioMedicine. 80:104060. PubMed
  170. Montero-Barrera D, et al. 2015. BioMed Res Int. 2015 615865. PubMed
  171. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  172. Kanatsu-Shinohara M, et al. 2022. J Reprod Dev. Online ahead of print. PubMed
  173. Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed
  174. Zhang Y, et al. 2021. Commun Biol. 344:4. PubMed
  175. Georgiadou A, et al. 2022. Elife. 11:. PubMed
  176. Xiao Y, et al. 2021. Cell. 184:6037. PubMed
  177. Lo W, et al. 2014. Elife. 14:1457. PubMed
  178. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  179. Hayashida E, et al. 2019. J Neuroinflammation. 0.789583333. PubMed
  180. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  181. Hosaka K, et al. 2020. Nat Commun. 3.030555556. PubMed
  182. Jia H, et al. 2018. Int J Oncol. 53:949. PubMed
  183. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  184. Yang N, et al. 2022. Nat Commun. 13:2336. PubMed
  185. Zheng Z, et al. 2021. Biomed Res Int. 2021:5535578. PubMed
  186. Rui J, et al. 2021. Nat Commun. 12:5074. PubMed
  187. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  188. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  189. Charlton J, et al. 2015. PLoS One. 10:119200. PubMed
  190. Lavoie S, et al. 2020. Gastroenterology. 158:1359. PubMed
  191. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  192. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  193. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  194. Ando T, et al. 2017. Inflammation. 10.1007/s10753-017-0613-6. PubMed
  195. Rosen SF, et al. 2022. Genome Med. 14:108. PubMed
  196. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  197. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  198. Ma C, et al. 2021. Mol Metab. 47:101170. PubMed
  199. Schadler K, et al. 2014. Cancer Res. 74:2171. PubMed
  200. L M, et al. 2016. Brain. 139: 1939-1957. PubMed
  201. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  202. Caetano MS, et al. 2019. Clin Cancer Res. 25:7576. PubMed
  203. Kashiwakura Y, et al. 2020. Clinical & Experimental Immunology. 202(1):119-135. PubMed
  204. Su M, et al. 2018. Immunol Cell Biol. 9:2448. PubMed
  205. Albaghdadi AJH, et al. 2019. Sci Rep. 9:6528. PubMed
  206. Luo Z, et al. 2020. J Virol. 94:00:00. PubMed
  207. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  208. Wang K, et al. 2021. Nat Commun. 12:4558. PubMed
  209. Mazumder S, et al. 2021. Heliyon. 7:e08124. PubMed
  210. Zhang M, et al. 2022. iScience. 25:104490. PubMed
  211. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  212. Fan X, et al. 2014. PLoS One. 9:107638. PubMed
  213. Fusciello M, et al. 2019. Nat Commun. 4.407638889. PubMed
  214. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  215. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  216. Liang Z, et al. 2022. iScience. 25:105233. PubMed
  217. Nakazawa S, et al. 2020. Sci Rep. 10:14559. PubMed
  218. Yang H, et al. 2022. Viruses. 14:. PubMed
  219. He C, et al. 2021. Immunol Cell Biol. 99:611. PubMed
  220. Sethuraman SN, et al. 2020. Theranostics. 10:3397. PubMed
  221. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
  222. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  223. Glasner A,et al. 2017. Sci Rep.. 10.1038/s41598-017-12998-w. PubMed
  224. Contijoch EJ et al. 2019. eLife. 8 pii: e40553. PubMed
  225. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  226. Taranto D, et al. 2021. Curr Protoc. 1:e147. PubMed
  227. Wu Y, et al. 2021. Immunity. 54:2595. PubMed
  228. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  229. Wang L, et al. 2022. ACS Pharmacol Transl Sci. 5:110. PubMed
  230. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  231. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  232. Campisi L, et al. 2022. Nature. 606:945. PubMed
  233. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  234. Simpson AP, et al. 2022. Cell Rep. 40:111099. PubMed
  235. Shi Z, et al. 2022. Br J Pharmacol. 179:5209. PubMed
  236. Kang IH, et al. 2022. iScience. 25:104818. PubMed
  237. TaSli PN, et al. 2022. J Food Biochem. 46:e14393. PubMed
  238. Sun Y, et al. 2023. Bioact Mater. 22:47. PubMed
  239. Gong F, et al. 2023. Adv Healthc Mater. 12:e2201771. PubMed
  240. VanDyke D, et al. 2022. Cell Rep. 41:111478. PubMed
  241. Chen X, et al. 2022. J Extracell Vesicles. 11:e12279. PubMed
  242. You Q, et al. 2023. Adv Mater. 35:e2204910. PubMed
  243. Wang R, et al. 2023. Nat Biomed Eng. 7:38. PubMed
  244. Edwards CL, et al. 2023. J Clin Invest. 133: . PubMed
  245. Cousin N, et al. 2022. Cells. 12: . PubMed
  246. Roh YJ, et al. 2023. Lab Anim Res. 39:2. PubMed
  247. Lu T, et al. 2023. Cancer Immunol Immunother. :. PubMed
  248. Lee JY, et al. 2023. Cancer Immunol Immunother. :. PubMed
  249. Patton T, et al. 2023. Cell Death Dis. 14:111. PubMed
  250. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  251. Han S, et al. 2022. Cancer Immunol Res. 10:437. PubMed
  252. Fang A, et al. 2022. J Virol. 96:e0105022. PubMed
  253. Dhalech AH, et al. 2022. J Virol. 96:e0123222. PubMed
  254. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  255. McGee MC, et al. 2022. Bio Protoc. 12:. PubMed
  256. Wu R, et al. 2022. Nat Immunol. 23:1536. PubMed
  257. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  258. Wang Y, et al. 2023. J Neuroinflammation. 20:41. PubMed
  259. Guo D, et al. 2023. Cell Biosci. 13:51. PubMed
  260. Tang C, et al. 2023. Nat Commun. 14:1493. PubMed
  261. Tao Q, et al. 2023. Microbiol Spectr. :e0522922. PubMed
  262. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  263. Chen F, et al. 2023. Acta Biomater. 164:387. PubMed
  264. Pandit M, et al. 2023. Nat Commun. 14:2593. PubMed
  265. Li M, et al. 2023. BMC Cancer. 23:497. PubMed
  266. Song S, et al. 2023. Bioact Mater. 28:358. PubMed
  267. Ye S, et al. 2023. Front Oncol. 13:1202750. PubMed
  268. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  269. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  270. Chen N, et al. 2021. Front Immunol. 12:756423. PubMed
  271. Berube A, et al. 2022. Viruses. 14:. PubMed
  272. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  273. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  274. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  275. Gerwing M, et al. 2020. Mol Imaging Biol. 1.959027778. PubMed
  276. Hong M, et al. 2021. Int J Mol Sci. 22:. PubMed
  277. Zhu W, et al. 2021. Onco Targets Ther. 14:2149. PubMed
  278. Geng Z, et al. 2021. Nat Commun. 12:6584. PubMed
  279. Zhu P, et al. 2012. J Cereb Blood Flow Metab. 0.482638889. PubMed
  280. Zhang S, et al. 2022. Acta Pharm Sin B. 12:3124. PubMed
  281. Schmidt V, et al. 2021. J Cell Biol. 220:. PubMed
  282. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  283. Zhang C, et al. 2022. J Extracell Vesicles. 11:e12209. PubMed
  284. Oh DS, et al. 2021. Autophagy. 17:2111. PubMed
  285. Gu H, et al. 2021. Immun Inflamm Dis. 9:1686. PubMed
  286. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  287. Tian X, et al. 2022. Front Immunol. 13:875236. PubMed
  288. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  289. Cai B, et al. 2021. Mol Cancer. 20:165. PubMed
  290. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  291. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  292. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  293. Oghumu S, et al. 2014. Immunology. 143: 109-119. PubMed
  294. Inoue M, et al. 2014. Proc Natl Acad Sci U S A. 111:5295. PubMed
  295. Lo W, Allen D 2012. Nat Immunol. 13:880. PubMed
  296. Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed
  297. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
  298. Britton GJ et al. 2019. Immunity. 50(1):212-224 . PubMed
  299. Yang X, et al. 2019. Oncotarget. 10:4180. PubMed
  300. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  301. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  302. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  303. Alissafi T, et al. 2020. Cell Metabolism. 32(4):591-604.e7. PubMed
  304. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  305. Li K, et al. 2022. J Immunother Cancer. 10:. PubMed
  306. Jia L, et al. 2022. Front Immunol. 13:897879. PubMed
  307. Hongu T, et al. 2022. Nat Cancer. 3:486. PubMed
  308. Canto F, et al. 2016. Sci Rep. 6:28573. PubMed
  309. Ben-Shaanan T, et al. 2016. Nat Med. 10.1038/nm.4133. PubMed
  310. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  311. Pein M, et al. 2020. Nat Commun. 11:1494. PubMed
  312. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  313. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  314. Wei SC, et al. 2020. Cancer Discov. . PubMed
  315. Khatun A, et al. 2021. J Exp Med. 218:. PubMed
  316. Si L, et al. 2022. Nat Biotechnol. 40:1370. PubMed
  317. Shin JE, et al. 2021. Heliyon. 7:e08433. PubMed
  318. Wu C, et al. 2014. J Mol Cell Cardiol. 76:33. PubMed
  319. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  320. Uceda-Castro R, et al. 2022. Cell Rep Med. 3:100821. PubMed
  321. Chen D, et al. 2020. Cancer Immunol Res. 8:883. PubMed
  322. Huang Y, et al. 2020. FASEB J. 34:1768. PubMed
  323. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  324. Freitas JT, et al. 2021. Pigment Cell Melanoma Res. 34:1084. PubMed
  325. Hu G, et al. 2022. Cell Death Dis. 13:640. PubMed
  326. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  327. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  328. Leisegang M, et al. 2016. Clin Cancer Res. 22: 2734 - 2743. PubMed
  329. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  330. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  331. Chisolm DA et al. 2019. Immunity. 51(1):155-168 . PubMed
  332. Li J, et al. 2020. Elife. 9:00. PubMed
  333. Abdul Pari AA, et al. 2020. Cancer Res. 80:2586. PubMed
  334. Wang Y, et al. 2021. Front Immunol. 12:654463. PubMed
  335. Ng SS, et al. 2020. Nat Immunol. 21:1205. PubMed
  336. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  337. Jing Y, et al. 2020. Sci Adv. 6:eaax9455. PubMed
  338. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  339. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  340. Ren G et al. 2017. Molecular cell. 67(6):1049-1058 . PubMed
  341. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  342. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  343. Tang X, et al. 2022. Cell Rep. 41:111673. PubMed
  344. Yang J, et al. 2020. Nature. 586:572. PubMed
  345. Takano T, et al. 2020. Front Immunol. 11:1555. PubMed
  346. Yang W, et al. 2020. Methods Mol Biol. 2111:91. PubMed
  347. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  348. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  349. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  350. Nakajima-Adachi H, et al. 2017. PLoS One. 12(2):e0172795. PubMed
  351. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  352. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  353. Alhosaini K, et al. 2021. Brain Sci. :11. PubMed
  354. Tan YY, et al. 2021. Exp Ther Med. 22:1368. PubMed
  355. Zhou Z, et al. 2022. Infect Immun. 90:e0045321. PubMed
  356. Toyama S, et al. 2021. Int J Mol Sci. 22:. PubMed
  357. Nikolos F, et al. 2022. Nat Commun. 13:1487. PubMed
  358. Clemens E, et al. 2015. J Immunol. 194:898. PubMed
  359. Coronel MM, et al. 2020. Sci Adv. 6:eaba5573. PubMed
  360. Bosnjak B, et al. 2019. Front Immunol. 10:840. PubMed
  361. Zou D, et al. 2020. EBioMedicine. 52:102652. PubMed
  362. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  363. Lu J, et al. 2021. Cell Death Discov. 7:165. PubMed
  364. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  365. Wang R, et al. 2022. Front Immunol. 13:947756. PubMed
  366. Li Z, et al. 2021. MBio. 12:e0254221. PubMed
  367. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  368. Anderson AE, et al. 2022. NPJ Regen Med. 7:6. PubMed
  369. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  370. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  371. Chulpanova DS, et al. 2021. Biology (Basel). 10:. PubMed
  372. Watson MJ, et al. 2021. Nature. 591:645. PubMed
  373. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  374. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  375. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  376. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  377. Shen DD, et al. 2022. Mol Cancer. 21:75. PubMed
  378. He C, et al. 2022. Nat Commun. 13:5459. PubMed
  379. Kwok T, et al. 2022. Front Aging. 3:838943. PubMed
  380. Miyauchi E, et al. 2020. Nature. 585:102. PubMed
  381. X X, et al. 2016. J Immunol . 197: 1683-1691. PubMed
  382. Yu X, et al. 2013. Cancer Res. 73:2093. PubMed
  383. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  384. Garcia-Dominguez D, et al. 2022. Front Immunol. 13:948335. PubMed
  385. Gomzikova MO, et al. 2020. Pharmaceutics. 12:00. PubMed
  386. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  387. Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
  388. Wang L, et al. 2021. Sci Adv. 7:eabj4796. PubMed
  389. Tsai HI, et al. 2021. EMBO Mol Med. 13:e12834. PubMed
  390. Zhu S, et al. 2022. EBioMedicine. 80:104060. PubMed
  391. Montero-Barrera D, et al. 2015. BioMed Res Int. 2015 615865. PubMed
  392. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  393. Kanatsu-Shinohara M, et al. 2022. J Reprod Dev. Online ahead of print. PubMed
  394. Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed
  395. Zhang Y, et al. 2021. Commun Biol. 344:4. PubMed
  396. Georgiadou A, et al. 2022. Elife. 11:. PubMed
  397. Xiao Y, et al. 2021. Cell. 184:6037. PubMed
  398. Lo W, et al. 2014. Elife. 14:1457. PubMed
  399. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  400. Hayashida E, et al. 2019. J Neuroinflammation. 0.789583333. PubMed
  401. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  402. Hosaka K, et al. 2020. Nat Commun. 3.030555556. PubMed
  403. Jia H, et al. 2018. Int J Oncol. 53:949. PubMed
  404. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  405. Yang N, et al. 2022. Nat Commun. 13:2336. PubMed
  406. Zheng Z, et al. 2021. Biomed Res Int. 2021:5535578. PubMed
  407. Rui J, et al. 2021. Nat Commun. 12:5074. PubMed
  408. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  409. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  410. Charlton J, et al. 2015. PLoS One. 10:119200. PubMed
  411. Lavoie S, et al. 2020. Gastroenterology. 158:1359. PubMed
  412. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  413. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  414. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  415. Ando T, et al. 2017. Inflammation. 10.1007/s10753-017-0613-6. PubMed
  416. Rosen SF, et al. 2022. Genome Med. 14:108. PubMed
  417. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  418. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  419. Ma C, et al. 2021. Mol Metab. 47:101170. PubMed
  420. Schadler K, et al. 2014. Cancer Res. 74:2171. PubMed
  421. L M, et al. 2016. Brain. 139: 1939-1957. PubMed
  422. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  423. Caetano MS, et al. 2019. Clin Cancer Res. 25:7576. PubMed
  424. Kashiwakura Y, et al. 2020. Clinical & Experimental Immunology. 202(1):119-135. PubMed
  425. Su M, et al. 2018. Immunol Cell Biol. 9:2448. PubMed
  426. Albaghdadi AJH, et al. 2019. Sci Rep. 9:6528. PubMed
  427. Luo Z, et al. 2020. J Virol. 94:00:00. PubMed
  428. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  429. Wang K, et al. 2021. Nat Commun. 12:4558. PubMed
  430. Mazumder S, et al. 2021. Heliyon. 7:e08124. PubMed
  431. Zhang M, et al. 2022. iScience. 25:104490. PubMed
  432. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  433. Fan X, et al. 2014. PLoS One. 9:107638. PubMed
  434. Fusciello M, et al. 2019. Nat Commun. 4.407638889. PubMed
  435. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  436. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  437. Liang Z, et al. 2022. iScience. 25:105233. PubMed
  438. Nakazawa S, et al. 2020. Sci Rep. 10:14559. PubMed
  439. Yang H, et al. 2022. Viruses. 14:. PubMed
  440. He C, et al. 2021. Immunol Cell Biol. 99:611. PubMed
  441. Sethuraman SN, et al. 2020. Theranostics. 10:3397. PubMed
  442. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
RRID
AB_312696 (BioLegend Cat. No. 100411)
AB_312697 (BioLegend Cat. No. 100412)

Antigen Details

Structure
Ig superfamily, 55 kD
Distribution

Majority of thymocytes, T cell subset

Function
TCR co-receptor, T cell activation
Ligand/Receptor
MHC class II molecule
Cell Type
Dendritic cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Bierer BE, et al. 1989. Annu. Rev. Immunol. 7:579.
3. Janeway CA. 1992. Annu. Rev. Immunol. 10:645.

Gene ID
12504 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org

Related FAQs

I am unable to see expression of T cell markers such as CD3 and CD4 post activation.
TCR-CD3 complexes on the T-lymphocyte surface are rapidly downregulated upon activation with peptide-MHC complex, superantigen or cross-linking with anti-TCR or anti-CD3 antibodies. PMA/Ionomycin treatment has been shown to downregulate surface CD4 expression. Receptor downregulation is a common biological phenomenon and so make sure that your stimulation treatment is not causing it in your sample type.

Other Formats

View All CD4 Reagents Request Custom Conjugation
Description Clone Applications
APC/Cyanine7 anti-mouse CD4 GK1.5 FC
Brilliant Violet 711™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 510™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 605™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 785™ anti-mouse CD4 GK1.5 FC
PE/Dazzle™ 594 anti-mouse CD4 GK1.5 FC
APC/Fire™ 750 anti-mouse CD4 GK1.5 FC
GoInVivo™ Purified anti-mouse CD4 GK1.5 FC
Brilliant Violet 750™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 650™ anti-mouse CD4 GK1.5 FC
Spark Blue™ 550 anti-mouse CD4 GK1.5 FC
Spark NIR™ 685 anti-mouse CD4 GK1.5 FC
KIRAVIA Blue 520™ anti-mouse CD4 GK1.5 FC
PE/Fire™ 640 anti-mouse CD4 GK1.5 FC
APC/Fire™ 810 anti-mouse CD4 GK1.5 FC
PE/Fire™ 700 anti-mouse CD4 GK1.5 FC
APC anti-mouse CD4 GK1.5 FC
Biotin anti-mouse CD4 GK1.5 FC,IHC-F,ICC
FITC anti-mouse CD4 GK1.5 FC
PE anti-mouse CD4 GK1.5 FC
PE/Cyanine5 anti-mouse CD4 GK1.5 FC
Purified anti-mouse CD4 GK1.5 FC,IHC-F,ICC,IP,Costim,Block,Depletion
Alexa Fluor® 647 anti-mouse CD4 GK1.5 FC,IHC-F
Alexa Fluor® 488 anti-mouse CD4 GK1.5 FC,IHC-F
Pacific Blue™ anti-mouse CD4 GK1.5 FC
Alexa Fluor® 700 anti-mouse CD4 GK1.5 FC
PerCP anti-mouse CD4 GK1.5 FC
PerCP/Cyanine5.5 anti-mouse CD4 GK1.5 FC
Brilliant Violet 421™ anti-mouse CD4 GK1.5 FC,ICC,IHC-F
Ultra-LEAF™ Purified anti-mouse CD4 GK1.5 FC,Block,Costim,Depletion,IHC,IP
Alexa Fluor® 594 anti-mouse CD4 GK1.5 IHC-F,FC,SB
Spark Violet™ 538 anti-mouse CD4 GK1.5 FC
Spark YG™ 593 anti-mouse CD4 GK1.5 FC
Spark Blue™ 574 anti-mouse CD4 Antibody GK1.5 FC
Spark UV™ 387 anti-mouse CD4 GK1.5 FC
Spark Blue™ 515 anti-mouse CD4 GK1.5 FC
Spark PLUS UV395™ anti-mouse CD4 GK1.5 FC
Spark Red™ 718 anti-mouse CD4 (Flexi-Fluor™) GK1.5 FC
PerCP/Fire™ 806 anti-mouse CD4 Antibody GK1.5 FC
PerCP/Fire™ 780 anti-mouse CD4 Antibody GK1.5 FC
Spark YG™ 581 anti-mouse CD4 (Flexi-Fluor™) GK1.5 FC
StarBright UltraViolet 795 anti-mouse CD4 GK1.5 FC
Spark PLUS V475™ anti-mouse CD4 GK1.5 FC
Spark PLUS B488™ anti-mouse CD4 GK1.5 FC

Customers Also Purchased

FITC anti-mouse CD3
Clone: 17A2

FITC anti-mouse CD4
Clone: GK1.5

PE anti-mouse CD8a
Clone: 53-6.7

PE anti-mouse CD4
Clone: GK1.5

Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
GK1.5 (See other available formats)
Regulatory Status
RUO
Other Names
L3T4, T4
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
GK1.5_APC_102110
C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) APC (filled histogram) or rat IgG2b, κ APC isotype control (open histogram).
  • GK1.5_APC_102110
    C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) APC (filled histogram) or rat IgG2b, κ APC isotype control (open histogram).
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
100411 25 µg DKK232
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100412 100 µg DKK785
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD4 is a 55 kD protein also known as L3T4 or T4. It is a member of the Ig superfamily, primarily expressed on most thymocytes, a subset of T cells, and weakly on macrophages and dendritic cells. It acts as a coreceptor with the TCR during T cell activation and thymic differentiation by binding MHC class II and associating with the protein tyrosin kinase, lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse CTL clone V4
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD4 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: blocking of CD4+ T cell activation1,4,11, thymocyte costimulation3, in vitro and in vivo depletion2,5-8, blocking of egg-sperm cell adhesion1,4, immunohistochemical staining of acetone-fixed frozen sections9,10, immunoprecipitation1,2, and spatial biology (IBEX)12,13. The GK1.5 antibody is able to block CD4 mediated cell adhesion and T cell activation. Binding of GK1.5 antibody to CD4 T cells can be blocked by RM4-5 antibody, but not RM4-4 antibody. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100442) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin < 0.01 EU/µg).

Application References
  1. Dialynas DP, et al. 1983. J. Immunol. 131:2445. (Block, IP)
  2. Dialynas DP, et al. 1983. Immunol. Rev. 74:29. (IP, Deplete)
  3. Wu L, et al. 1991. J. Exp. Med. 174:1617. (Costim)
  4. Godfrey DI, et al. 1994. J. Immunol. 152:4783. (Block)
  5. Gavett SH, et al. 1994. Am. J. Respir. Cell. Mol. Biol. 10:587. (Deplete)
  6. Schuyler M, et al. 1994. Am. J. Respir. Crit. Care Med. 149:1286. (Deplete)
  7. Ghobrial RR, et al. 1989. Clin. Immunol. Immunopathol. 52:486. (Deplete)
  8. Israelski DM, et al. 1989. J. Immunol. 142:954. (Deplete)
  9. Zheng B, et al. 1996. J. Exp. Med. 184:1083. (IHC)
  10. Frei K, et al. 1997. J. Exp. Med. 185:2177. (IHC)
  11. Felix NJ, et al. 2007. Nat. Immunol. 8:388. (Block)
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  2. Glasner A,et al. 2017. Sci Rep.. 10.1038/s41598-017-12998-w. PubMed
  3. Contijoch EJ et al. 2019. eLife. 8 pii: e40553. PubMed
  4. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  5. Taranto D, et al. 2021. Curr Protoc. 1:e147. PubMed
  6. Wu Y, et al. 2021. Immunity. 54:2595. PubMed
  7. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  8. Wang L, et al. 2022. ACS Pharmacol Transl Sci. 5:110. PubMed
  9. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  10. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  11. Campisi L, et al. 2022. Nature. 606:945. PubMed
  12. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  13. Simpson AP, et al. 2022. Cell Rep. 40:111099. PubMed
  14. Shi Z, et al. 2022. Br J Pharmacol. 179:5209. PubMed
  15. Kang IH, et al. 2022. iScience. 25:104818. PubMed
  16. TaSli PN, et al. 2022. J Food Biochem. 46:e14393. PubMed
  17. Sun Y, et al. 2023. Bioact Mater. 22:47. PubMed
  18. Gong F, et al. 2023. Adv Healthc Mater. 12:e2201771. PubMed
  19. VanDyke D, et al. 2022. Cell Rep. 41:111478. PubMed
  20. Chen X, et al. 2022. J Extracell Vesicles. 11:e12279. PubMed
  21. You Q, et al. 2023. Adv Mater. 35:e2204910. PubMed
  22. Wang R, et al. 2023. Nat Biomed Eng. 7:38. PubMed
  23. Edwards CL, et al. 2023. J Clin Invest. 133: . PubMed
  24. Cousin N, et al. 2022. Cells. 12: . PubMed
  25. Roh YJ, et al. 2023. Lab Anim Res. 39:2. PubMed
  26. Lu T, et al. 2023. Cancer Immunol Immunother. :. PubMed
  27. Lee JY, et al. 2023. Cancer Immunol Immunother. :. PubMed
  28. Patton T, et al. 2023. Cell Death Dis. 14:111. PubMed
  29. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  30. Han S, et al. 2022. Cancer Immunol Res. 10:437. PubMed
  31. Fang A, et al. 2022. J Virol. 96:e0105022. PubMed
  32. Dhalech AH, et al. 2022. J Virol. 96:e0123222. PubMed
  33. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  34. McGee MC, et al. 2022. Bio Protoc. 12:. PubMed
  35. Wu R, et al. 2022. Nat Immunol. 23:1536. PubMed
  36. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  37. Wang Y, et al. 2023. J Neuroinflammation. 20:41. PubMed
  38. Guo D, et al. 2023. Cell Biosci. 13:51. PubMed
  39. Tang C, et al. 2023. Nat Commun. 14:1493. PubMed
  40. Tao Q, et al. 2023. Microbiol Spectr. :e0522922. PubMed
  41. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  42. Chen F, et al. 2023. Acta Biomater. 164:387. PubMed
  43. Pandit M, et al. 2023. Nat Commun. 14:2593. PubMed
  44. Li M, et al. 2023. BMC Cancer. 23:497. PubMed
  45. Song S, et al. 2023. Bioact Mater. 28:358. PubMed
  46. Ye S, et al. 2023. Front Oncol. 13:1202750. PubMed
  47. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  48. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  49. Chen N, et al. 2021. Front Immunol. 12:756423. PubMed
  50. Berube A, et al. 2022. Viruses. 14:. PubMed
  51. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  52. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  53. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  54. Gerwing M, et al. 2020. Mol Imaging Biol. 1.959027778. PubMed
  55. Hong M, et al. 2021. Int J Mol Sci. 22:. PubMed
  56. Zhu W, et al. 2021. Onco Targets Ther. 14:2149. PubMed
  57. Geng Z, et al. 2021. Nat Commun. 12:6584. PubMed
  58. Zhu P, et al. 2012. J Cereb Blood Flow Metab. 0.482638889. PubMed
  59. Zhang S, et al. 2022. Acta Pharm Sin B. 12:3124. PubMed
  60. Schmidt V, et al. 2021. J Cell Biol. 220:. PubMed
  61. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  62. Zhang C, et al. 2022. J Extracell Vesicles. 11:e12209. PubMed
  63. Oh DS, et al. 2021. Autophagy. 17:2111. PubMed
  64. Gu H, et al. 2021. Immun Inflamm Dis. 9:1686. PubMed
  65. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  66. Tian X, et al. 2022. Front Immunol. 13:875236. PubMed
  67. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  68. Cai B, et al. 2021. Mol Cancer. 20:165. PubMed
  69. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  70. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  71. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  72. Oghumu S, et al. 2014. Immunology. 143: 109-119. PubMed
  73. Inoue M, et al. 2014. Proc Natl Acad Sci U S A. 111:5295. PubMed
  74. Lo W, Allen D 2012. Nat Immunol. 13:880. PubMed
  75. Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed
  76. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
  77. Britton GJ et al. 2019. Immunity. 50(1):212-224 . PubMed
  78. Yang X, et al. 2019. Oncotarget. 10:4180. PubMed
  79. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  80. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  81. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  82. Alissafi T, et al. 2020. Cell Metabolism. 32(4):591-604.e7. PubMed
  83. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  84. Li K, et al. 2022. J Immunother Cancer. 10:. PubMed
  85. Jia L, et al. 2022. Front Immunol. 13:897879. PubMed
  86. Hongu T, et al. 2022. Nat Cancer. 3:486. PubMed
  87. Canto F, et al. 2016. Sci Rep. 6:28573. PubMed
  88. Ben-Shaanan T, et al. 2016. Nat Med. 10.1038/nm.4133. PubMed
  89. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  90. Pein M, et al. 2020. Nat Commun. 11:1494. PubMed
  91. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  92. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  93. Wei SC, et al. 2020. Cancer Discov. . PubMed
  94. Khatun A, et al. 2021. J Exp Med. 218:. PubMed
  95. Si L, et al. 2022. Nat Biotechnol. 40:1370. PubMed
  96. Shin JE, et al. 2021. Heliyon. 7:e08433. PubMed
  97. Wu C, et al. 2014. J Mol Cell Cardiol. 76:33. PubMed
  98. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  99. Uceda-Castro R, et al. 2022. Cell Rep Med. 3:100821. PubMed
  100. Chen D, et al. 2020. Cancer Immunol Res. 8:883. PubMed
  101. Huang Y, et al. 2020. FASEB J. 34:1768. PubMed
  102. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  103. Freitas JT, et al. 2021. Pigment Cell Melanoma Res. 34:1084. PubMed
  104. Hu G, et al. 2022. Cell Death Dis. 13:640. PubMed
  105. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  106. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  107. Leisegang M, et al. 2016. Clin Cancer Res. 22: 2734 - 2743. PubMed
  108. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  109. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  110. Chisolm DA et al. 2019. Immunity. 51(1):155-168 . PubMed
  111. Li J, et al. 2020. Elife. 9:00. PubMed
  112. Abdul Pari AA, et al. 2020. Cancer Res. 80:2586. PubMed
  113. Wang Y, et al. 2021. Front Immunol. 12:654463. PubMed
  114. Ng SS, et al. 2020. Nat Immunol. 21:1205. PubMed
  115. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  116. Jing Y, et al. 2020. Sci Adv. 6:eaax9455. PubMed
  117. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  118. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  119. Ren G et al. 2017. Molecular cell. 67(6):1049-1058 . PubMed
  120. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  121. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  122. Tang X, et al. 2022. Cell Rep. 41:111673. PubMed
  123. Yang J, et al. 2020. Nature. 586:572. PubMed
  124. Takano T, et al. 2020. Front Immunol. 11:1555. PubMed
  125. Yang W, et al. 2020. Methods Mol Biol. 2111:91. PubMed
  126. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  127. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  128. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  129. Nakajima-Adachi H, et al. 2017. PLoS One. 12(2):e0172795. PubMed
  130. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  131. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  132. Alhosaini K, et al. 2021. Brain Sci. :11. PubMed
  133. Tan YY, et al. 2021. Exp Ther Med. 22:1368. PubMed
  134. Zhou Z, et al. 2022. Infect Immun. 90:e0045321. PubMed
  135. Toyama S, et al. 2021. Int J Mol Sci. 22:. PubMed
  136. Nikolos F, et al. 2022. Nat Commun. 13:1487. PubMed
  137. Clemens E, et al. 2015. J Immunol. 194:898. PubMed
  138. Coronel MM, et al. 2020. Sci Adv. 6:eaba5573. PubMed
  139. Bosnjak B, et al. 2019. Front Immunol. 10:840. PubMed
  140. Zou D, et al. 2020. EBioMedicine. 52:102652. PubMed
  141. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  142. Lu J, et al. 2021. Cell Death Discov. 7:165. PubMed
  143. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  144. Wang R, et al. 2022. Front Immunol. 13:947756. PubMed
  145. Li Z, et al. 2021. MBio. 12:e0254221. PubMed
  146. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  147. Anderson AE, et al. 2022. NPJ Regen Med. 7:6. PubMed
  148. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  149. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  150. Chulpanova DS, et al. 2021. Biology (Basel). 10:. PubMed
  151. Watson MJ, et al. 2021. Nature. 591:645. PubMed
  152. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  153. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  154. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  155. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  156. Shen DD, et al. 2022. Mol Cancer. 21:75. PubMed
  157. He C, et al. 2022. Nat Commun. 13:5459. PubMed
  158. Kwok T, et al. 2022. Front Aging. 3:838943. PubMed
  159. Miyauchi E, et al. 2020. Nature. 585:102. PubMed
  160. X X, et al. 2016. J Immunol . 197: 1683-1691. PubMed
  161. Yu X, et al. 2013. Cancer Res. 73:2093. PubMed
  162. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  163. Garcia-Dominguez D, et al. 2022. Front Immunol. 13:948335. PubMed
  164. Gomzikova MO, et al. 2020. Pharmaceutics. 12:00. PubMed
  165. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  166. Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
  167. Wang L, et al. 2021. Sci Adv. 7:eabj4796. PubMed
  168. Tsai HI, et al. 2021. EMBO Mol Med. 13:e12834. PubMed
  169. Zhu S, et al. 2022. EBioMedicine. 80:104060. PubMed
  170. Montero-Barrera D, et al. 2015. BioMed Res Int. 2015 615865. PubMed
  171. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  172. Kanatsu-Shinohara M, et al. 2022. J Reprod Dev. Online ahead of print. PubMed
  173. Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed
  174. Zhang Y, et al. 2021. Commun Biol. 344:4. PubMed
  175. Georgiadou A, et al. 2022. Elife. 11:. PubMed
  176. Xiao Y, et al. 2021. Cell. 184:6037. PubMed
  177. Lo W, et al. 2014. Elife. 14:1457. PubMed
  178. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  179. Hayashida E, et al. 2019. J Neuroinflammation. 0.789583333. PubMed
  180. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  181. Hosaka K, et al. 2020. Nat Commun. 3.030555556. PubMed
  182. Jia H, et al. 2018. Int J Oncol. 53:949. PubMed
  183. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  184. Yang N, et al. 2022. Nat Commun. 13:2336. PubMed
  185. Zheng Z, et al. 2021. Biomed Res Int. 2021:5535578. PubMed
  186. Rui J, et al. 2021. Nat Commun. 12:5074. PubMed
  187. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  188. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  189. Charlton J, et al. 2015. PLoS One. 10:119200. PubMed
  190. Lavoie S, et al. 2020. Gastroenterology. 158:1359. PubMed
  191. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  192. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  193. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  194. Ando T, et al. 2017. Inflammation. 10.1007/s10753-017-0613-6. PubMed
  195. Rosen SF, et al. 2022. Genome Med. 14:108. PubMed
  196. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  197. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  198. Ma C, et al. 2021. Mol Metab. 47:101170. PubMed
  199. Schadler K, et al. 2014. Cancer Res. 74:2171. PubMed
  200. L M, et al. 2016. Brain. 139: 1939-1957. PubMed
  201. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  202. Caetano MS, et al. 2019. Clin Cancer Res. 25:7576. PubMed
  203. Kashiwakura Y, et al. 2020. Clinical & Experimental Immunology. 202(1):119-135. PubMed
  204. Su M, et al. 2018. Immunol Cell Biol. 9:2448. PubMed
  205. Albaghdadi AJH, et al. 2019. Sci Rep. 9:6528. PubMed
  206. Luo Z, et al. 2020. J Virol. 94:00:00. PubMed
  207. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  208. Wang K, et al. 2021. Nat Commun. 12:4558. PubMed
  209. Mazumder S, et al. 2021. Heliyon. 7:e08124. PubMed
  210. Zhang M, et al. 2022. iScience. 25:104490. PubMed
  211. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  212. Fan X, et al. 2014. PLoS One. 9:107638. PubMed
  213. Fusciello M, et al. 2019. Nat Commun. 4.407638889. PubMed
  214. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  215. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  216. Liang Z, et al. 2022. iScience. 25:105233. PubMed
  217. Nakazawa S, et al. 2020. Sci Rep. 10:14559. PubMed
  218. Yang H, et al. 2022. Viruses. 14:. PubMed
  219. He C, et al. 2021. Immunol Cell Biol. 99:611. PubMed
  220. Sethuraman SN, et al. 2020. Theranostics. 10:3397. PubMed
  221. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
  222. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  223. Glasner A,et al. 2017. Sci Rep.. 10.1038/s41598-017-12998-w. PubMed
  224. Contijoch EJ et al. 2019. eLife. 8 pii: e40553. PubMed
  225. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  226. Taranto D, et al. 2021. Curr Protoc. 1:e147. PubMed
  227. Wu Y, et al. 2021. Immunity. 54:2595. PubMed
  228. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  229. Wang L, et al. 2022. ACS Pharmacol Transl Sci. 5:110. PubMed
  230. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  231. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  232. Campisi L, et al. 2022. Nature. 606:945. PubMed
  233. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  234. Simpson AP, et al. 2022. Cell Rep. 40:111099. PubMed
  235. Shi Z, et al. 2022. Br J Pharmacol. 179:5209. PubMed
  236. Kang IH, et al. 2022. iScience. 25:104818. PubMed
  237. TaSli PN, et al. 2022. J Food Biochem. 46:e14393. PubMed
  238. Sun Y, et al. 2023. Bioact Mater. 22:47. PubMed
  239. Gong F, et al. 2023. Adv Healthc Mater. 12:e2201771. PubMed
  240. VanDyke D, et al. 2022. Cell Rep. 41:111478. PubMed
  241. Chen X, et al. 2022. J Extracell Vesicles. 11:e12279. PubMed
  242. You Q, et al. 2023. Adv Mater. 35:e2204910. PubMed
  243. Wang R, et al. 2023. Nat Biomed Eng. 7:38. PubMed
  244. Edwards CL, et al. 2023. J Clin Invest. 133: . PubMed
  245. Cousin N, et al. 2022. Cells. 12: . PubMed
  246. Roh YJ, et al. 2023. Lab Anim Res. 39:2. PubMed
  247. Lu T, et al. 2023. Cancer Immunol Immunother. :. PubMed
  248. Lee JY, et al. 2023. Cancer Immunol Immunother. :. PubMed
  249. Patton T, et al. 2023. Cell Death Dis. 14:111. PubMed
  250. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  251. Han S, et al. 2022. Cancer Immunol Res. 10:437. PubMed
  252. Fang A, et al. 2022. J Virol. 96:e0105022. PubMed
  253. Dhalech AH, et al. 2022. J Virol. 96:e0123222. PubMed
  254. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  255. McGee MC, et al. 2022. Bio Protoc. 12:. PubMed
  256. Wu R, et al. 2022. Nat Immunol. 23:1536. PubMed
  257. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  258. Wang Y, et al. 2023. J Neuroinflammation. 20:41. PubMed
  259. Guo D, et al. 2023. Cell Biosci. 13:51. PubMed
  260. Tang C, et al. 2023. Nat Commun. 14:1493. PubMed
  261. Tao Q, et al. 2023. Microbiol Spectr. :e0522922. PubMed
  262. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  263. Chen F, et al. 2023. Acta Biomater. 164:387. PubMed
  264. Pandit M, et al. 2023. Nat Commun. 14:2593. PubMed
  265. Li M, et al. 2023. BMC Cancer. 23:497. PubMed
  266. Song S, et al. 2023. Bioact Mater. 28:358. PubMed
  267. Ye S, et al. 2023. Front Oncol. 13:1202750. PubMed
  268. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  269. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  270. Chen N, et al. 2021. Front Immunol. 12:756423. PubMed
  271. Berube A, et al. 2022. Viruses. 14:. PubMed
  272. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  273. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  274. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  275. Gerwing M, et al. 2020. Mol Imaging Biol. 1.959027778. PubMed
  276. Hong M, et al. 2021. Int J Mol Sci. 22:. PubMed
  277. Zhu W, et al. 2021. Onco Targets Ther. 14:2149. PubMed
  278. Geng Z, et al. 2021. Nat Commun. 12:6584. PubMed
  279. Zhu P, et al. 2012. J Cereb Blood Flow Metab. 0.482638889. PubMed
  280. Zhang S, et al. 2022. Acta Pharm Sin B. 12:3124. PubMed
  281. Schmidt V, et al. 2021. J Cell Biol. 220:. PubMed
  282. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  283. Zhang C, et al. 2022. J Extracell Vesicles. 11:e12209. PubMed
  284. Oh DS, et al. 2021. Autophagy. 17:2111. PubMed
  285. Gu H, et al. 2021. Immun Inflamm Dis. 9:1686. PubMed
  286. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  287. Tian X, et al. 2022. Front Immunol. 13:875236. PubMed
  288. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  289. Cai B, et al. 2021. Mol Cancer. 20:165. PubMed
  290. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  291. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  292. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  293. Oghumu S, et al. 2014. Immunology. 143: 109-119. PubMed
  294. Inoue M, et al. 2014. Proc Natl Acad Sci U S A. 111:5295. PubMed
  295. Lo W, Allen D 2012. Nat Immunol. 13:880. PubMed
  296. Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed
  297. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
  298. Britton GJ et al. 2019. Immunity. 50(1):212-224 . PubMed
  299. Yang X, et al. 2019. Oncotarget. 10:4180. PubMed
  300. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  301. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  302. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  303. Alissafi T, et al. 2020. Cell Metabolism. 32(4):591-604.e7. PubMed
  304. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  305. Li K, et al. 2022. J Immunother Cancer. 10:. PubMed
  306. Jia L, et al. 2022. Front Immunol. 13:897879. PubMed
  307. Hongu T, et al. 2022. Nat Cancer. 3:486. PubMed
  308. Canto F, et al. 2016. Sci Rep. 6:28573. PubMed
  309. Ben-Shaanan T, et al. 2016. Nat Med. 10.1038/nm.4133. PubMed
  310. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  311. Pein M, et al. 2020. Nat Commun. 11:1494. PubMed
  312. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  313. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  314. Wei SC, et al. 2020. Cancer Discov. . PubMed
  315. Khatun A, et al. 2021. J Exp Med. 218:. PubMed
  316. Si L, et al. 2022. Nat Biotechnol. 40:1370. PubMed
  317. Shin JE, et al. 2021. Heliyon. 7:e08433. PubMed
  318. Wu C, et al. 2014. J Mol Cell Cardiol. 76:33. PubMed
  319. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  320. Uceda-Castro R, et al. 2022. Cell Rep Med. 3:100821. PubMed
  321. Chen D, et al. 2020. Cancer Immunol Res. 8:883. PubMed
  322. Huang Y, et al. 2020. FASEB J. 34:1768. PubMed
  323. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  324. Freitas JT, et al. 2021. Pigment Cell Melanoma Res. 34:1084. PubMed
  325. Hu G, et al. 2022. Cell Death Dis. 13:640. PubMed
  326. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  327. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  328. Leisegang M, et al. 2016. Clin Cancer Res. 22: 2734 - 2743. PubMed
  329. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  330. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  331. Chisolm DA et al. 2019. Immunity. 51(1):155-168 . PubMed
  332. Li J, et al. 2020. Elife. 9:00. PubMed
  333. Abdul Pari AA, et al. 2020. Cancer Res. 80:2586. PubMed
  334. Wang Y, et al. 2021. Front Immunol. 12:654463. PubMed
  335. Ng SS, et al. 2020. Nat Immunol. 21:1205. PubMed
  336. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  337. Jing Y, et al. 2020. Sci Adv. 6:eaax9455. PubMed
  338. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  339. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  340. Ren G et al. 2017. Molecular cell. 67(6):1049-1058 . PubMed
  341. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  342. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  343. Tang X, et al. 2022. Cell Rep. 41:111673. PubMed
  344. Yang J, et al. 2020. Nature. 586:572. PubMed
  345. Takano T, et al. 2020. Front Immunol. 11:1555. PubMed
  346. Yang W, et al. 2020. Methods Mol Biol. 2111:91. PubMed
  347. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  348. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  349. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  350. Nakajima-Adachi H, et al. 2017. PLoS One. 12(2):e0172795. PubMed
  351. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  352. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  353. Alhosaini K, et al. 2021. Brain Sci. :11. PubMed
  354. Tan YY, et al. 2021. Exp Ther Med. 22:1368. PubMed
  355. Zhou Z, et al. 2022. Infect Immun. 90:e0045321. PubMed
  356. Toyama S, et al. 2021. Int J Mol Sci. 22:. PubMed
  357. Nikolos F, et al. 2022. Nat Commun. 13:1487. PubMed
  358. Clemens E, et al. 2015. J Immunol. 194:898. PubMed
  359. Coronel MM, et al. 2020. Sci Adv. 6:eaba5573. PubMed
  360. Bosnjak B, et al. 2019. Front Immunol. 10:840. PubMed
  361. Zou D, et al. 2020. EBioMedicine. 52:102652. PubMed
  362. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  363. Lu J, et al. 2021. Cell Death Discov. 7:165. PubMed
  364. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  365. Wang R, et al. 2022. Front Immunol. 13:947756. PubMed
  366. Li Z, et al. 2021. MBio. 12:e0254221. PubMed
  367. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  368. Anderson AE, et al. 2022. NPJ Regen Med. 7:6. PubMed
  369. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  370. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  371. Chulpanova DS, et al. 2021. Biology (Basel). 10:. PubMed
  372. Watson MJ, et al. 2021. Nature. 591:645. PubMed
  373. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  374. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  375. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  376. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  377. Shen DD, et al. 2022. Mol Cancer. 21:75. PubMed
  378. He C, et al. 2022. Nat Commun. 13:5459. PubMed
  379. Kwok T, et al. 2022. Front Aging. 3:838943. PubMed
  380. Miyauchi E, et al. 2020. Nature. 585:102. PubMed
  381. X X, et al. 2016. J Immunol . 197: 1683-1691. PubMed
  382. Yu X, et al. 2013. Cancer Res. 73:2093. PubMed
  383. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  384. Garcia-Dominguez D, et al. 2022. Front Immunol. 13:948335. PubMed
  385. Gomzikova MO, et al. 2020. Pharmaceutics. 12:00. PubMed
  386. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  387. Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
  388. Wang L, et al. 2021. Sci Adv. 7:eabj4796. PubMed
  389. Tsai HI, et al. 2021. EMBO Mol Med. 13:e12834. PubMed
  390. Zhu S, et al. 2022. EBioMedicine. 80:104060. PubMed
  391. Montero-Barrera D, et al. 2015. BioMed Res Int. 2015 615865. PubMed
  392. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  393. Kanatsu-Shinohara M, et al. 2022. J Reprod Dev. Online ahead of print. PubMed
  394. Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed
  395. Zhang Y, et al. 2021. Commun Biol. 344:4. PubMed
  396. Georgiadou A, et al. 2022. Elife. 11:. PubMed
  397. Xiao Y, et al. 2021. Cell. 184:6037. PubMed
  398. Lo W, et al. 2014. Elife. 14:1457. PubMed
  399. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  400. Hayashida E, et al. 2019. J Neuroinflammation. 0.789583333. PubMed
  401. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  402. Hosaka K, et al. 2020. Nat Commun. 3.030555556. PubMed
  403. Jia H, et al. 2018. Int J Oncol. 53:949. PubMed
  404. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  405. Yang N, et al. 2022. Nat Commun. 13:2336. PubMed
  406. Zheng Z, et al. 2021. Biomed Res Int. 2021:5535578. PubMed
  407. Rui J, et al. 2021. Nat Commun. 12:5074. PubMed
  408. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  409. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  410. Charlton J, et al. 2015. PLoS One. 10:119200. PubMed
  411. Lavoie S, et al. 2020. Gastroenterology. 158:1359. PubMed
  412. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  413. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  414. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  415. Ando T, et al. 2017. Inflammation. 10.1007/s10753-017-0613-6. PubMed
  416. Rosen SF, et al. 2022. Genome Med. 14:108. PubMed
  417. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  418. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  419. Ma C, et al. 2021. Mol Metab. 47:101170. PubMed
  420. Schadler K, et al. 2014. Cancer Res. 74:2171. PubMed
  421. L M, et al. 2016. Brain. 139: 1939-1957. PubMed
  422. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  423. Caetano MS, et al. 2019. Clin Cancer Res. 25:7576. PubMed
  424. Kashiwakura Y, et al. 2020. Clinical & Experimental Immunology. 202(1):119-135. PubMed
  425. Su M, et al. 2018. Immunol Cell Biol. 9:2448. PubMed
  426. Albaghdadi AJH, et al. 2019. Sci Rep. 9:6528. PubMed
  427. Luo Z, et al. 2020. J Virol. 94:00:00. PubMed
  428. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  429. Wang K, et al. 2021. Nat Commun. 12:4558. PubMed
  430. Mazumder S, et al. 2021. Heliyon. 7:e08124. PubMed
  431. Zhang M, et al. 2022. iScience. 25:104490. PubMed
  432. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  433. Fan X, et al. 2014. PLoS One. 9:107638. PubMed
  434. Fusciello M, et al. 2019. Nat Commun. 4.407638889. PubMed
  435. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  436. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  437. Liang Z, et al. 2022. iScience. 25:105233. PubMed
  438. Nakazawa S, et al. 2020. Sci Rep. 10:14559. PubMed
  439. Yang H, et al. 2022. Viruses. 14:. PubMed
  440. He C, et al. 2021. Immunol Cell Biol. 99:611. PubMed
  441. Sethuraman SN, et al. 2020. Theranostics. 10:3397. PubMed
  442. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
RRID
AB_312696 (BioLegend Cat. No. 100411)
AB_312697 (BioLegend Cat. No. 100412)

Antigen Details

Structure
Ig superfamily, 55 kD
Distribution

Majority of thymocytes, T cell subset

Function
TCR co-receptor, T cell activation
Ligand/Receptor
MHC class II molecule
Cell Type
Dendritic cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Bierer BE, et al. 1989. Annu. Rev. Immunol. 7:579.
3. Janeway CA. 1992. Annu. Rev. Immunol. 10:645.

Gene ID
12504 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org

Related FAQs

I am unable to see expression of T cell markers such as CD3 and CD4 post activation.
TCR-CD3 complexes on the T-lymphocyte surface are rapidly downregulated upon activation with peptide-MHC complex, superantigen or cross-linking with anti-TCR or anti-CD3 antibodies. PMA/Ionomycin treatment has been shown to downregulate surface CD4 expression. Receptor downregulation is a common biological phenomenon and so make sure that your stimulation treatment is not causing it in your sample type.

Other Formats

View All CD4 Reagents Request Custom Conjugation
Description Clone Applications
APC/Cyanine7 anti-mouse CD4 GK1.5 FC
Brilliant Violet 711™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 510™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 605™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 785™ anti-mouse CD4 GK1.5 FC
PE/Dazzle™ 594 anti-mouse CD4 GK1.5 FC
APC/Fire™ 750 anti-mouse CD4 GK1.5 FC
GoInVivo™ Purified anti-mouse CD4 GK1.5 FC
Brilliant Violet 750™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 650™ anti-mouse CD4 GK1.5 FC
Spark Blue™ 550 anti-mouse CD4 GK1.5 FC
Spark NIR™ 685 anti-mouse CD4 GK1.5 FC
KIRAVIA Blue 520™ anti-mouse CD4 GK1.5 FC
PE/Fire™ 640 anti-mouse CD4 GK1.5 FC
APC/Fire™ 810 anti-mouse CD4 GK1.5 FC
PE/Fire™ 700 anti-mouse CD4 GK1.5 FC
APC anti-mouse CD4 GK1.5 FC
Biotin anti-mouse CD4 GK1.5 FC,IHC-F,ICC
FITC anti-mouse CD4 GK1.5 FC
PE anti-mouse CD4 GK1.5 FC
PE/Cyanine5 anti-mouse CD4 GK1.5 FC
Purified anti-mouse CD4 GK1.5 FC,IHC-F,ICC,IP,Costim,Block,Depletion
Alexa Fluor® 647 anti-mouse CD4 GK1.5 FC,IHC-F
Alexa Fluor® 488 anti-mouse CD4 GK1.5 FC,IHC-F
Pacific Blue™ anti-mouse CD4 GK1.5 FC
Alexa Fluor® 700 anti-mouse CD4 GK1.5 FC
PerCP anti-mouse CD4 GK1.5 FC
PerCP/Cyanine5.5 anti-mouse CD4 GK1.5 FC
Brilliant Violet 421™ anti-mouse CD4 GK1.5 FC,ICC,IHC-F
Ultra-LEAF™ Purified anti-mouse CD4 GK1.5 FC,Block,Costim,Depletion,IHC,IP
Alexa Fluor® 594 anti-mouse CD4 GK1.5 IHC-F,FC,SB
Spark Violet™ 538 anti-mouse CD4 GK1.5 FC
Spark YG™ 593 anti-mouse CD4 GK1.5 FC
Spark Blue™ 574 anti-mouse CD4 Antibody GK1.5 FC
Spark UV™ 387 anti-mouse CD4 GK1.5 FC
Spark Blue™ 515 anti-mouse CD4 GK1.5 FC
Spark PLUS UV395™ anti-mouse CD4 GK1.5 FC
Spark Red™ 718 anti-mouse CD4 (Flexi-Fluor™) GK1.5 FC
PerCP/Fire™ 806 anti-mouse CD4 Antibody GK1.5 FC
PerCP/Fire™ 780 anti-mouse CD4 Antibody GK1.5 FC
Spark YG™ 581 anti-mouse CD4 (Flexi-Fluor™) GK1.5 FC
StarBright UltraViolet 795 anti-mouse CD4 GK1.5 FC
Spark PLUS V475™ anti-mouse CD4 GK1.5 FC
Spark PLUS B488™ anti-mouse CD4 GK1.5 FC

Customers Also Purchased

FITC anti-mouse CD3
Clone: 17A2

FITC anti-mouse CD4
Clone: GK1.5

PE anti-mouse CD8a
Clone: 53-6.7

PE anti-mouse CD4
Clone: GK1.5

Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account